Mobilisation After Endovascular Stroke Treatment

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorKarolinska Institutet

About this trial

The goal of this observational study is to learn how the timing of mobilisation after endovascular thrombectomy (EVT) affects complications in patients with acute ischaemic stroke. The main questions it aims to answer are:

Does mobilisation approximately 12 hours after EVT, compared to approximately 24 hours after EVT, affect the risk of complications such as access site haematoma (ASH), venous thromboembolism (VTE), infections, and delirium? How common are these complications after EVT, and which factors are associated with increased risk?

Participants undergoing EVT as part of their regular stroke care at two hospitals with different mobilisation routines will be followed during their hospital stay. Researchers will collect information about mobilisation timing, complications, clinical assessments, and medical history using case report forms, electronic health records, and national stroke registries.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Undergone endovascular thrombectomy for acute ischaemic stroke

Minimum 18 years old

Disqualifiers

Residing from outside primary catchment area

Spending more than 24 hrs in ICU post thrombectomy

Trial population

Adult patients with acute ischaemic stroke treated with endovascular thrombectomy.

Trial design

Design model

Cohort

Time perspective

Prospective

Treatments tested in this trial

  • Mobilisation

    Other intervention

    Out of bed mobilisation, such as sitting on the edge of the bed, standing or walking with or without support.

Treatment groups

400 Participants
are divided into 2 treatment groups
Group A: Later mobilisation1 intervention
Group B: Earlier mobilisation1 intervention

Trial outcomes

Primary outcomes

1

Access site haematoma

Bleeding from puncture site

Time frame
From completion of endovascular thrombectomy (baseline) to discharge from the stroke unit, up to 5 days.

Secondary outcomes

1

sICH

Symptomatic intracranial haemorrhage

Time frame
Within 36 hours after completion of endovascular thrombectomy
2

Venous thromboembolism

Blood clots in venous system, such as deep vein thrombosis and/or pulmonary embolism.

Time frame
From completion of endovascular thrombectomy until discharge from the acute care hospital, assessed up to approximately 30 days.
3

Infections

Urinary tract infections, pneumonia and/or sepsis.

Time frame
From completion of endovascular thrombectomy until discharge from the acute care hospital, assessed up to approximately 30 days.
4

Delirium

Acute confusion, identified with Confusion Assessment Method for the Intensive Care Unit (CAM-ICU)

Time frame
From completion of endovascular thrombectomy (Baseline) to discharge from the stroke unit, up to 5 days.

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Karolinska Institutet

Lead sponsor

Tampere University Hospital

Collaborator

Region Stockholm

Collaborator